{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:18:16Z","timestamp":1793607496808,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Institutes of Health (NIH)\/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) research career development grant","award":["K23AR060274"],"award-info":[{"award-number":["K23AR060274"]}],"id":[{"id":"https:\/\/ror.org\/006zn3t30","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.jaad.2014.03.030","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T16:46:18Z","timestamp":1399653978000},"page":"327-349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":760,"title":["Guidelines of care for the management of atopic\u00a0dermatitis"],"prefix":"10.1016","volume":"71","author":[{"given":"Robert","family":"Sidbury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6819-6044","authenticated-orcid":false,"given":"Dawn M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly M.","family":"Cordoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy G.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James N.","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Chamlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon M.","family":"Hanifin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfons","family":"Krol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Paller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7718-1749","authenticated-orcid":false,"given":"Kathryn","family":"Schwarzenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wynnis L.","family":"Tom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hywel C.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Elmets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Harrod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy Smith","family":"Begolka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence F.","family":"Eichenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2014.03.030_bib1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaad.2003.08.003","article-title":"Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)\/American Academy of Dermatology Association \u201cadministrative regulations for evidence-based clinical practice guidelines\u201d","volume":"50","author":"Hanifin","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-5945-11-10","article-title":"Mapping randomized controlled trials of treatments for eczema\u2013the GREAT database (the Global Resource of EczemA Trials: a collection of key data on randomized controlled trials of treatments for eczema from 2000 to 2010)","volume":"11","author":"Nankervis","year":"2011","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib3","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1468-3083.2012.04635.x","article-title":"Guidelines for treatment of atopic eczema (atopic dermatitis), part I","volume":"26","author":"Ring","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2014.03.030_bib4","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1468-3083.2012.04636.x","article-title":"Guidelines for treatment of atopic eczema (atopic dermatitis), part II","volume":"26","author":"Ring","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2014.03.030_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jaci.2012.12.672","article-title":"Atopic dermatitis: a practice parameter update 2012","volume":"131","author":"Schneider","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2014.03.030_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3122\/jabfm.17.1.59","article-title":"Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature","volume":"17","author":"Ebell","year":"2004","journal-title":"J Am Board Fam Pract"},{"key":"10.1016\/j.jaad.2014.03.030_bib7","unstructured":"American Academy of Dermatology. Administrative regulations; evidence-based clinical practice guidelines. Available from: URL:www.aad.org\/Forms\/Policies\/Uploads\/AR\/AR%20-%20Evidence-Based%20Clinical%20Guideline.pdf. Accessed November 2011."},{"key":"10.1016\/j.jaad.2014.03.030_bib8","first-page":"229","article-title":"Treatment of psoriasis","volume":"24","author":"Goeckerman","year":"1925","journal-title":"Northwest Med"},{"key":"10.1016\/j.jaad.2014.03.030_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2133.1978.tb07329.x","article-title":"Oral psoralen photochemotherapy of atopic eczema","volume":"98","author":"Morison","year":"1978","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1600-0781.2007.00291.x","article-title":"Phototherapy in the management of atopic dermatitis: a systematic review","volume":"23","author":"Meduri","year":"2007","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jaad.2014.03.030_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0781.2008.00328.x","article-title":"Efficacy of UVA1 phototherapy in 230 patients with various skin\u00a0diseases","volume":"24","author":"Rombold","year":"2008","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jaad.2014.03.030_bib12","first-page":"28","article-title":"The treatment of severe atopic dermatitis in childhood with narrowband ultraviolet B phototherapy","volume":"32","author":"Clayton","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib13","first-page":"697","article-title":"UVB phototherapy of atopic dermatitis","volume":"119","author":"Jekler","year":"1988","journal-title":"Br\u00a0J\u00a0Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib14","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0190-9622(99)70090-3","article-title":"Phototherapy for atopic eczema with narrow-band UVB","volume":"40","author":"Grundmann-Kollmann","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib15","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1525-1470.1996.tb00711.x","article-title":"Experience with UVB phototherapy in children","volume":"13","author":"Tay","year":"1996","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaad.2009.08.026","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis, section 5: guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy","volume":"62","author":"Menter","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib17","unstructured":"Astellas. Medication guide (tacrolimus). Available from: URL:http:\/\/www.protopic.com\/pdf\/protopic_med_guide.pdf. Accessed May 1, 2013."},{"key":"10.1016\/j.jaad.2014.03.030_bib18","unstructured":"Medicis. Prescribing information (pimecrolimus). Available from: URL:http:\/\/elidel-us.com\/files\/Elidel_PI.pdf. Accessed May 1, 2013."},{"key":"10.1016\/j.jaad.2014.03.030_bib19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archderm.134.5.595","article-title":"Consensus workshop on the toxic effects of long-term PUVA therapy","volume":"134","author":"Morison","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib20","unstructured":"Goldsmith LK, Katz SI, Gilchrest B, Paller A, Lefell D, Wolff K. Fitzpatrick's dermatology in general medicine. 8th ed. New\u00a0York: McGraw-Hill; 2012."},{"key":"10.1016\/j.jaad.2014.03.030_bib21","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM199704103361501","article-title":"Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA follow-up study","volume":"336","author":"Stern","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2014.03.030_bib22","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1346-8138.2003.tb00415.x","article-title":"Treatment of persistent severe atopic dermatitis in 113 Japanese patients with oral psoralen photo-chemotherapy","volume":"30","author":"Uetsu","year":"2003","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0923-1811(93)90105-X","article-title":"A proposed guideline for psoralen photochemotherapy (PUVA) with atopic dermatitis: successful therapeutic effect on severe and intractable cases","volume":"5","author":"Yoshiike","year":"1993","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2014.03.030_bib24","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1365-2133.1988.tb02597.x","article-title":"The role of psoralen photochemotherapy (PUVA) in the treatment of severe atopic eczema in adolescents","volume":"118","author":"Atherton","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2230.2006.02061.x","article-title":"Narrowband ultraviolet B (UVB) phototherapy in children","volume":"31","author":"Jury","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib26","first-page":"34","article-title":"Pimecrolimus and narrowband UVB as monotherapy or combination therapy in children and adolescents with atopic dermatitis","volume":"86","author":"Tzung","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2014.03.030_bib27","doi-asserted-by":"crossref","first-page":"b1542","DOI":"10.1136\/bmj.b1542","article-title":"Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicenter randomized controlled non-inferiority trial (PLUTO study)","volume":"338","author":"Koek","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2014.03.030_bib28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1468-3083.2006.01495.x","article-title":"Treatment of atopic dermatitis with the xenon chloride excimer laser","volume":"20","author":"Baltas","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2014.03.030_bib29","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2302\/kjm.42.174","article-title":"Clinical application of low reactive level laser therapy (LLLT) for atopic dermatitis","volume":"42","author":"Morita","year":"1993","journal-title":"Keio J Med"},{"key":"10.1016\/j.jaad.2014.03.030_bib30","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2230.2007.02644.x","article-title":"A pilot study showing pulsed-dye laser treatment improves localized areas of chronic atopic dermatitis","volume":"33","author":"Syed","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib31","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1346-8138.2004.tb00638.x","article-title":"Bicenter experience in the treatment of severe generalized atopic dermatitis with extracorporeal photochemotherapy","volume":"31","author":"Radenhausen","year":"2004","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0190-9622(99)70440-8","article-title":"Long-term application of extracorporeal photochemotherapy in severe atopic dermatitis","volume":"40","author":"Prinz","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaci.2011.03.024","article-title":"A randomized trial of methotrexate versus azathioprine for severe atopic eczema","volume":"128","author":"Schram","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2014.03.030_bib34","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jaad.2010.04.027","article-title":"Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial","volume":"64","author":"Haeck","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib35","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2133.2009.09561.x","article-title":"Prednisolone vs cyclosporin for severe adult eczema: an investigator-initiated double-blind placebo-controlled multicenter trial","volume":"162","author":"Schmitt","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta4370","article-title":"Systematic review of treatments for atopic eczema","volume":"4","author":"Hoare","year":"2000","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jaad.2014.03.030_bib37","series-title":"A multicenter double-blind placebo controlled crossover to assess the efficacy and safety of cyclosporin A in adult patients with severe refractory atopic dermatitis","author":"Allen","year":"1991"},{"key":"10.1016\/j.jaad.2014.03.030_bib38","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2133.1994.tb13111.x","article-title":"Cyclosporin in atopic dermatitis: a multicenter placebo-controlled study","volume":"130","author":"van Joost","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib39","first-page":"653","article-title":"A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life","volume":"42","author":"Czech","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000018065","article-title":"Comparison of two formulations of cyclosporin A in the treatment of severe atopic dermatitis: a double-blind, single-center, cross-over pilot study","volume":"198","author":"Zurbriggen","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2014.03.030_bib41","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1468-3083.2006.02023.x","article-title":"Cyclosporin in the treatment of patients with atopic eczema\u2013a systematic review and meta-analysis","volume":"21","author":"Schmitt","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2014.03.030_bib42","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaad.2009.03.027","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis, section 4: guidelines of care for the management and treatment of psoriasis with traditional systemic agents","volume":"61","author":"Menter","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib43","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1365-2133.2000.03241.x","article-title":"Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy","volume":"142","author":"Harper","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib44","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(06)68340-2","article-title":"Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomized controlled trial","volume":"367","author":"Meggitt","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2014.03.030_bib45","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1365-2133.2002.04989.x","article-title":"Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial","volume":"147","author":"Berth-Jones","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib46","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2133.2008.08610.x","article-title":"Azathioprine treatment photosensitizes human skin to ultraviolet A radiation","volume":"159","author":"Perrett","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib47","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/archdermatol.2009.81","article-title":"Thioguanine nucleotides and thiopurine methyltransferase in immunobullous diseases: optimal levels\u00a0as adjunctive tools for azathioprine monitoring","volume":"145","author":"el-Azhary","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaad.2012.07.001","article-title":"Oral azathioprine for recalcitrant pediatric atopic dermatitis: clinical response and thiopurine monitoring","volume":"68","author":"Caufield","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib49","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1200\/JCO.2001.19.8.2293","article-title":"Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine","volume":"19","author":"Evans","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2014.03.030_bib50","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1046\/j.1365-2133.2002.04922.x","article-title":"A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at high risk of myelosuppression","volume":"147","author":"Murphy","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/09546630802512646","article-title":"Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults","volume":"20","author":"Hon","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2014.03.030_bib52","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2133.2006.07686.x","article-title":"An\u00a0open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema","volume":"156","author":"Weatherhead","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib53","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1468-3083.2009.03351.x","article-title":"Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults","volume":"24","author":"Lyakhovitsky","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2014.03.030_bib54","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jaad.2008.11.906","article-title":"Methotrexate and psoriasis: 2009 National Psoriasis Foundation consensus conference","volume":"60","author":"Kalb","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib55","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00431-012-1893-3","article-title":"Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt","volume":"172","author":"El-Khalawany","year":"2013","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaad.2014.03.030_bib56","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jaad.2004.07.043","article-title":"Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature","volume":"52","author":"Dadlani","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib57","first-page":"23","article-title":"Mycophenolate mofetil therapy for moderate to severe atopic dermatitis","volume":"32","author":"Murray","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib58","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2133.2007.07947.x","article-title":"Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients","volume":"157","author":"Heller","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib59","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0190-9622(93)70026-P","article-title":"Recombinant interferon gamma therapy for atopic dermatitis","volume":"28","author":"Hanifin","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib60","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1067\/mjd.2000.104793","article-title":"Clinical\u00a0improvement and immunohistochemical findings in severe atopic dermatitis treated with interferon gamma","volume":"42","author":"Jang","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib61","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.clinthera.2004.11.017","article-title":"Relationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic\/pharmacodynamic model","volume":"26","author":"Daley-Yates","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaad.2014.03.030_bib62","first-page":"990","article-title":"Omalizumab therapy in atopic dermatitis: depletion of IgE does not\u00a0improve the clinical course\u2013a randomized, placebo-controlled and double blind pilot study","volume":"8","author":"Heil","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2014.03.030_bib63","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jaad.2011.10.033","article-title":"Open-label, pilot study examining sequential therapy with oral tacrolimus and topical tacrolimus for severe atopic dermatitis","volume":"67","author":"Keaney","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib64","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1067\/mai.2001.118598","article-title":"Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis","volume":"108","author":"Boguniewicz","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2014.03.030_bib65","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2133.2010.09743.x","article-title":"Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review","volume":"163","author":"Bath-Hextall","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib66","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1046\/j.1365-2133.1998.02271.x","article-title":"Flucloxacillin in the treatment of atopic dermatitis","volume":"138","author":"Ewing","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib67","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0011-393X(05)80509-0","article-title":"The use of cefadroxil in superinfected atopic dermatitis","volume":"52","author":"Weinberg","year":"1992","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.jaad.2014.03.030_bib68","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1542\/peds.2011-0948","article-title":"Delayed acyclovir and outcomes of children hospitalized with eczema herpeticum","volume":"128","author":"Aronson","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2014.03.030_bib69","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1034\/j.1399-3038.2002.01047.x","article-title":"Early Treatment of the Atopic Child Study Group. Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months","volume":"13","author":"Diepgen","year":"2002","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaad.2014.03.030_bib70","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2340\/00015555-1360","article-title":"Relieving the pruritus of atopic dermatitis: a meta-analysis","volume":"92","author":"Sher","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2014.03.030_bib71","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1001\/archderm.135.12.1522","article-title":"An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis","volume":"135","author":"Klein","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib72","first-page":"127","article-title":"Dose ranging study: cetirizine in the treatment of atopic dermatitis in adults","volume":"70","author":"Hannuksela","year":"1993","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaad.2014.03.030_bib73","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/archderm.1964.01590280048008","article-title":"A blind study","volume":"89","author":"Epstein","year":"1964","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2014.03.030_bib74","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2500\/aap2008.29.3080","article-title":"Antihistamines in the pediatric population: achieving optimal outcomes when treating seasonal allergic rhinitis and chronic urticaria","volume":"29","author":"Schad","year":"2008","journal-title":"Allergy Asthma Proc"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221401264X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221401264X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:30:38Z","timestamp":1759271438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096221401264X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S019096221401264X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2014.03.030","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guidelines of care for the management of atopic\u00a0dermatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2014.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}